Otsuka Pharmaceutical

United Therapeutics Corporation is a biotechnology firm focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. The company develops technology platforms for prostacyclin analogs, immunotherapeutic monoclonal antibodies, glycobiology and telemedicine. It performs activities for cardiovascular health, including the development of analogs of the endogenous hormone prostacyclin for the treatment of pulmonary arterial hypertension and critical limb ischemia. United Therapeutics telemedicine services are focused on patients with an array of possible cardiac arrhythmias. The company s IMA therapies are designed to combat ovarian, prostate, breast, lung, pancreatic and colorectal cancers. Its glycobiology compounds target hepatitis C and other infectious diseases. United Therapeutics strategy is balanced among mature programs, pivotal development and early-stage pipeline activities. The company is headquartered in Silver Spring, Md.

Founded in 1975, Shimadzu Scientific Instruments provide analytical solutions for a range of laboratories in the United States. The company offers a variety of analytical, application and dual-range balances, as well as electronic printers. It provides a range of testing and inspection machines, such as hardness testers, high-speed video cameras, powders and particle size analyzers, and viscosity and flow testing instruments. Shimadzu Scientific Instruments has a network of more than 50 locations that offers local and regional sales and technical support services. It is a subsidiary of Shimadzu Corporation, which is a multinational corporation that operates medical diagnostics, analytical instruments, and aerospace and industrial divisions.

Lupin Pharmaceuticals specializes in the design and development of a variety of generic medicines. Operational since 2003, the company s facilities are approved by the Food and Drug Administration. It develops and markets a range of drugs for children under the Suprax brand. The company maintains more than 10 manufacturing facilities in the United States. Lupin Pharmaceuticals is a wholly owned subsidiary of Lupin Limited, which is one of the leading pharmaceutical companies in India. With annual revenues of over $690 million, Lupin Limited maintains a research and development center in Pune in India. The company specializes in the development of drugs for the treatment of diabetes.